$820.34
+
$5.28 (0.65%)
End-of-day quote: 05/31/2024
NYSE:LLY
Eli Lilly and Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr927.30 | kr917.22 | 0.00% | 14 | kr4.11T |
| MRK | Merck | NYSE | Outperform | $125.54 | $141.88 | 0.00% | 11 | $317.97B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.90 | £134.03 | 0.00% | 16 | £188.97B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $567.98 | $627.47 | 0.00% | 1 | $216.81B |
| NOVN | Novartis | SWX | Hold | CHF93.17 | CHF99.32 | 0.00% | 9 | CHF190.10B |
| ROG | Roche Holding | SWX | Hold | CHF231.00 | CHF277.53 | 0.00% | 9 | CHF186.49B |
| ABT | Abbott Laboratories | NYSE | Outperform | $102.19 | $125.59 | 0.00% | 7 | $177.77B |
| AMGN | Amgen | NasdaqGS | Outperform | $305.85 | $316.27 | 0.00% | 8 | $164.07B |
| PFE | Pfizer | NYSE | Outperform | $28.66 | $31.92 | 0.00% | 6 | $162.40B |
| SAN | Sanofi | ENXTPA | Outperform | 89.76€ | 108.19€ | 0.00% | 9 | 112.21€B |
| GSK | GSK | LSE | Outperform | £17.67 | £20.35 | 0.00% | 12 | £72.04B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $41.09 | $53.19 | 0.00% | 10 | $83.29B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $64.27 | $82.77 | 0.00% | 14 | $80.07B |
| ZTS | Zoetis | NYSE | Outperform | $169.56 | $211.20 | 0.00% | 5 | $77.37B |
| MRNA | Moderna | NasdaqGS | Outperform | $142.55 | $138.77 | 0.00% | 1 | $54.63B |
| 4519 | Chugai Pharmaceutical | TSE | Outperform | ¥4.78k | ¥5.98k | 0.00% | 0 | ¥7.87T |
| SUNPHARMA | Sun Pharmaceutical Industries | NSEI | Outperform | Rp1.46k | Rp1.59k | 0.00% | 25 | Rp3.50T |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.17k | ¥4.80k | 0.00% | 0 | ¥6.55T |
| BAYN | Bayer | XTRA | Hold | 28.24€ | 36.64€ | 0.00% | 4 | 27.74€B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.93 | $17.84 | 0.00% | 9 | $19.17B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $148.43 | $220.38 | 0.00% | 7 | $18.78B |
| BGNE | BeiGene | NasdaqGS | Buy | $148.85 | $267.01 | 0.00% | 2 | $15.56B |
| DGX | Quest Diagnostics | NYSE | Outperform | $141.97 | $147.00 | 0.00% | 8 | $15.77B |
| 4507 | Shionogi & | TSE | Outperform | ¥7.04k | ¥7.12k | 0.00% | 0 | ¥2.16T |
| BIM | bioMérieux | ENXTPA | Outperform | 97.15€ | 105.55€ | 0.00% | 1 | 11.73€B |
| 4523 | Eisai | TSE | Outperform | ¥6.75k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| FME | Fresenius Medical Care AG & Co... | XTRA | Hold | 39.18€ | 41.13€ | 0.00% | 12 | 11.38€B |
| IPN | Ipsen | ENXTPA | Outperform | 120.60€ | 127.95€ | 0.00% | 0 | 9.88€B |
| 4528 | Ono Pharmaceutical | TSE | Hold | ¥2.28k | ¥2.76k | 0.00% | 0 | ¥1.09T |
| ITCI | Intra-Cellular Therapies | NasdaqGS | Outperform | $67.24 | $79.10 | 0.00% | 10 | $6.86B |
| BPMC | Blueprint Medicines | NasdaqGS | Outperform | $105.56 | $85.71 | 0.00% | 5 | $6.78B |
| EXEL | Exelixis | NasdaqGS | Outperform | $21.69 | $26.44 | 0.00% | 5 | $6.34B |
| ZEAL | Zealand Pharma A/S | CPSE | Buy | kr639.50 | kr357.00 | 0.00% | 2 | kr38.52B |
| HALO | Halozyme Therapeutics | NasdaqGS | Outperform | $44.29 | $47.50 | 0.00% | 3 | $5.58B |
| HLUN A | H. Lundbeck A/S | CPSE | Outperform | kr37.74 | kr190.00 | 0.00% | 6 | kr36.60B |
| ALKS | Alkermes | NasdaqGS | Outperform | $23.40 | $33.27 | 0.00% | 3 | $4.11B |
| NNI | Nelnet | NYSE | Hold | $103.66 | $95.00 | 0.00% | 1 | $3.63B |
| VIRP | Virbac | ENXTPA | Outperform | 358.00€ | 348.34€ | 0.00% | 5 | 2.98€B |
| 300529 | Jafron Biomedical | SZSE | Buy | ¥27.58 | ¥26.62 | 0.00% | 0 | ¥22.72B |
| BHC | Bausch Health Companies | NYSE | Hold | $6.56 | $9.50 | 0.00% | 5 | $2.55B |
| 4506 | Sumitomo Pharma | TSE | Underperform | ¥464.00 | ¥0.00 | 0.00% | 0 | ¥396.90B |
| INDV | Indivior PLC | LSE | Buy | £14.45 | £28.89 | 0.00% | 4 | £1.95B |
| PFIZER | Pfizer | NSEI | Outperform | Rp4.61k | Rp4.53k | 0.00% | 3 | Rp204.63B |
| AMPH | Amphastar Pharmaceuticals | NasdaqGS | Outperform | $42.33 | $69.00 | 0.00% | 0 | $2.09B |
| VETO | Vetoquinol | ENXTPA | Hold | 102.00€ | 106.50€ | 0.00% | 0 | 1.12€B |
| OPK | OPKO Health | NasdaqGS | Outperform | $1.01 | $6.70 | 0.00% | 0 | $1.18B |
| HIMX | Himax Technologies | NasdaqGS | Outperform | $6.50 | $7.00 | 0.00% | 1 | $995.93M |
| 524735 | Hikal | BSE | Buy | Rp284.90 | Rp328.00 | 0.00% | 1 | Rp36.36B |
| AMRN | Amarin | NasdaqGM | Hold | $0.87 | $2.05 | 0.00% | 1 | $378.19M |
| VNDA | Vanda Pharmaceuticals | NasdaqGM | Outperform | $5.11 | $4.25 | 0.00% | 0 | $311.94M |
| XERS | Xeris Biopharma Holdings | NasdaqGS | Buy | $2.26 | $4.60 | 0.00% | 1 | $260.93M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $1.82 | $10.86 | 0.00% | 3 | $255.37M |
| PBYI | Puma Biotechnology | NasdaqGS | Hold | $3.85 | $4.67 | 0.00% | 2 | $232.99M |
| OOMA | Ooma | NYSE | Buy | $8.64 | $18.60 | 0.00% | 4 | $208.73M |
| EDT | Spectral Medical | TSX | Buy | C$0.49 | C$1.60 | 0.00% | 0 | C$167.15M |
| CODA | Coda Octopus Group | NasdaqCM | Buy | $5.69 | $8.00 | 0.00% | 0 | $66.93M |
| BIOC | GlaxoSmithKline S.A.E | CASE | - | £28.12 | £0.00 | 0.00% | 0 | £2.36B |
| CTSO | Cytosorbents | NasdaqCM | Outperform | $0.90 | $4.50 | 0.00% | 1 | $47.35M |
| MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.16 | $0.65 | 0.00% | 0 | $44.04M |
| ECOR | electroCore | NasdaqCM | Buy | $6.43 | $22.75 | 0.00% | 1 | $41.12M |
| PMN | ProMIS Neurosciences | NasdaqCM | Outperform | $1.84 | $18.49 | 0.00% | 0 | $34.98M |
| POXEL | Poxel | ENXTPA | - | 0.63€ | 3.50€ | 0.00% | 0 | 25.85€M |
| ACST | Acasti Pharma | NasdaqCM | Buy | $2.73 | $16.34 | 0.00% | 0 | $26.98M |
| ORGS | Orgenesis | NasdaqCM | - | $0.28 | $9.00 | 0.00% | 0 | $16.26M |
| LXXG.Q | LexaGene Holdings | OTCPK | - | $0.11 | $0.75 | 0.00% | 0 | $11.34M |
| 542934 | Chandra Bhagat Pharma | BSE | - | Rp101.25 | Rp0.00 | 0.00% | 0 | Rp859.76M |
| ULGX | Urologix | OTCPK | - | $0.00 | $1.50 | 0.00% | 0 | $0.00M |
| CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
